Abiopharma

Avantor, Inc. - Avantor® to Report Fourth Quarter and Full Year 2025 Earnings on Wednesday, February 11, 2026

Geron - Geron Corporation Provides 2026 Financial Guidance

BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2025 Unaudited Revenue from Continuing Operations

Avantor® to Report Fourth Quarter and Full Year 2025 Earnings on Wednesday, February 11, 2026

Harmony Biosciences Guides to Over $1 Billion in WAKIX® Revenue in 2026; Advancing Robust Late-Stage Pipeline With Potential for Long-term Value Creation

MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results

Solid Biosciences Doses First Participant in First-in-Class Phase 1b FALCON Trial Evaluating SGT-212 Dual-Route Gene Therapy for the Treatment of Friedreich’s Ataxia

Rigel Provides Business Update and 2026 Outlook

Butterfly Network, Inc. - Butterfly Network Reports Preliminary, Unaudited Fourth Quarter 2025 Revenue Growth of at least 17% Year over Year

Vir Biotechnology - Vir Biotechnology Provides Updates on Chronic Hepatitis Delta and Oncology Programs and Upcoming 2026 Clinical Milestones